Insider · CIK 0001362635

Lenk Robert P

Reports to the SEC for 2 companies · AUSTIN, TX

sec.gov

Transactions

Companies

Filings

CIK

0001362635

Forms 4 and 5

Insider transactions

20 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-08-22	CNSYCERENOME, INC.P Purchase	Director	PPurchase	+110K sh	$0.49	+$53.8K	139,327
2025-08-13	CNSYCERENOME, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+298K sh	—	—	297,794
2025-02-18	CNSYCERENOME, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+40.1K sh	—	—	40,122
2024-09-11	CNSYCERENOME, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+3,650 sh	—	—	3,650
2024-05-08	CNSYCERENOME, INC.P Purchase	Director	PPurchase	+4,167 sh	$2.04	+$8,500.68	29,327
2024-05-08	CNSYCERENOME, INC. · Warrants (Right to buy)A Award	Director	AAward	+8,334 sh	—	—	8,334
2024-02-22	CNSYCERENOME, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+2,250 sh	—	—	2,250
2023-11-16	CNSYCERENOME, INC.P Purchase	Director	PPurchase	+1,000 sh	$1.95	+$1,950	25,160
2023-11-15	CNSYCERENOME, INC.P Purchase	Director	PPurchase	+1,000 sh	$1.77	+$1,770	24,160
2023-11-13	CNSYCERENOME, INC.P Purchase	Director	PPurchase	+4,000 sh	$1.43	+$5,720	23,160
2023-11-10	CNSYCERENOME, INC.P Purchase	Director	PPurchase	+2,000 sh	$1.45	+$2,900	19,160
2023-11-09	CNSYCERENOME, INC.P Purchase	Director	PPurchase	+4,199 sh	$1.59	+$6,676.41	17,160
2023-11-08	CNSYCERENOME, INC.P Purchase	Director	PPurchase	+5,000 sh	$1.65	+$8,250	12,961
2023-11-07	CNSYCERENOME, INC.P Purchase	Director	PPurchase	+6,000 sh	$1.64	+$9,840	7,961
2023-11-06	CNSYCERENOME, INC.P Purchase	Director	PPurchase	+1,395 sh	$1.50	+$2,092.5	1,961
2022-12-30	CNSYCERENOME, INC.S Sale	Director	SSale	−1,500 sh	$0.31	−$472.05	8,500
2021-09-13	CNSYCERENOME, INC.P Purchase	Director	PPurchase	+7,000 sh	$1.86	+$13K	10,000
2021-05-25	CNSYCERENOME, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+6,336 sh	—	—	6,336
2020-08-25	CNSYCERENOME, INC.P Purchase	Director	PPurchase	+3,000 sh	$2.49	+$7,464.9	3,000
2020-06-25	CNSYCERENOME, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000

Recent filings

Accepted (ET)
Aug 254
Lenk Robert P0000950170-25-111092
SEC(opens sec.gov)
Aug 154
Lenk Robert P0000950170-25-109410
SEC(opens sec.gov)
Feb 204
Lenk Robert P0000950170-25-024342
SEC(opens sec.gov)
Sep 124
Lenk Robert P0000950170-24-105961
SEC(opens sec.gov)
May 104
Lenk Robert P0000950170-24-057451
SEC(opens sec.gov)
Feb 264
Lenk Robert P0000950170-24-020415
SEC(opens sec.gov)
Nov 174
Lenk Robert P0001209191-23-055638
SEC(opens sec.gov)
Nov 154
Lenk Robert P0001209191-23-055264
SEC(opens sec.gov)
Nov 134
Lenk Robert P0001209191-23-054914
SEC(opens sec.gov)
Nov 84
Lenk Robert P0001209191-23-054650
SEC(opens sec.gov)
Jan 44
Lenk Robert P0001209191-23-001447
SEC(opens sec.gov)
Sep 154
Lenk Robert P0001209191-21-056096
SEC(opens sec.gov)
May 274
Lenk Robert P0001209191-21-036240
SEC(opens sec.gov)
Aug 264
Lenk Robert P0001209191-20-048319
SEC(opens sec.gov)
Jun 294
Lenk Robert P0001209191-20-039325
SEC(opens sec.gov)

Companies

Address

C/O PLUS THERAPEUTICS INC. 4200 MARATHON BOULEVARD, SUITE 200

AUSTIN, TX, 78756